Treatment for CSCR found to have “no benefit”
New research from the University of Bristol and University Hospital Southampton has concluded that eplerenone offers no benefit for patients ...
New research from the University of Bristol and University Hospital Southampton has concluded that eplerenone offers no benefit for patients ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited